• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

SuperDimension Inc.

Medtronic’s Navigate lung trial enrolls 1st European patient

March 10, 2016 By Brad Perriello

Medtronic (NYSE:MDT) said today that it enrolled the 1st European patient in a huge, real-world study of the SuperDimension lung device it acquired along with Covidien early last year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm post-market study […]

Filed Under: Clinical Trials, Imaging Tagged With: Covidien, Medtronic, Medtronic buys Covidien, Pulmonary, SuperDimension Inc.

Covidien unveils next-gen superDimension device

October 27, 2014 By Brad Perriello Leave a Comment

Covidien unveils next-gen superDimension device

Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.

Filed Under: News Well, Software / IT Tagged With: Covidien, Pulmonary, SuperDimension Inc.

MAKO’s plunge may be good news for buyers | Wall Street Beat

May 17, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Mako Surgical (NSDQ:MAKO) has had a tough month on Wall Street, with shares having lost 45% since the end of April, but not everyone is running for the hills.

Earlier this week a company director, Frederick Moll, picked up another 5,000 shares at $24.15 each, representing the 1st insider buy on the open market since late last year.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Abiomed, Aetna, Athenahealth Inc., BSD Medical Corp., Covidien, Deals Roundup, Dehaier Medical Systems Ltd., MAKO Surgical Corp., NxStage Medical Inc., SuperDimension Inc.

MassDevice.com +3 | The top 3 med-tech stories for March 19, 2012.

March 19, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Legal News, Mergers & Acquisitions, News Well, Pre-Market Approval (PMA), Wall Street Beat Tagged With: Boston Scientific, Cameron Health Inc., Covidien, Kensey Nash Corp., stjudemedical, SuperDimension Inc.

Covidien confirms superDimension buyout

March 19, 2012 By MassDevice staff Leave a Comment

Covidien

Covidien (NYSE:COV) confirmed that it’s agreed to acquire medical device maker superDimension, saying it will pay about $300 million plus possible earnouts in a deal expected to close during the 2nd quarter.

The Mansfield, Mass.-based medical products giant said it plans to integrate superDimension, which makes the i-Logic pulmonology device, into its medical device segment’s endomechanical portfolio.

Filed Under: Diagnostics, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Covidien, Pulmonary, SuperDimension Inc.

Report: Covidien to acquire superDimension for $350M | Wall Street Beat

March 14, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Covidien (NYSE:COV) is set to close a $350 million buyout of Israeli lung diagnosis firm superDimension by the end of the week, according to Israeli business journal Calcalist.

Founded in Tel Aviv by Pinchas Gilboa, Minneapolis-based superDimension, which employs about 120 people worldwide, also has offices in Dusseldorf, Germany.

Filed Under: Diagnostics, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: BioDirection, Boston Scientific, BSN Medical, Cameron Health Inc., CardioInsight Technologies Inc., Covidien, Debt Financing, Eloquest Healthcare, Foundation Medical Partners, Functional Neuromodulation, GE Healthcare, Integrated Healing Technologies, Irrimax Corp., Kensey Nash Corp., Linet, Nanosys, Novation, Omeros Corp., Philips, Premier Inc., pSivida Corp., Pulmonary, SuperDimension Inc., ViewRay Inc., Viking Systems Inc.

Ban metal-on-metal hips, say U.K. researchers | MassDevice.com On Call

March 13, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — A team of U.K. researchers is calling for a ban on metal-on-metal hip implants, citing studies that demonstrate that they fail more often than other artificial hips, especially when used in women.

Filed Under: Legal News, Medicare, Mergers & Acquisitions, News Well, Recalls Tagged With: Consumers Union, Hips, Johnson and Johnson, OptiMedica Corp., Stryker, SuperDimension Inc., Zimmer Biomet

SuperDimension reels in $25 million

September 14, 2010 By MedCity News Leave a Comment

MedCity News logo

SuperDimension Inc. raised $24.8 million, according to the Globes news service.

The Plymouth, Minn.-based startup, which also has offices in Israel and Germany, is developing GPS-like technology designed to detect early stages of lung cancer. Dubbed electromagnetic navigation bronchoscopy, SuperDimension’s system allows doctors to probe the deepest regions of the lungs, guided by sensors and 3D mapping software.

Filed Under: Business/Financial News, Diagnostics, News Well, Oncology Tagged With: SuperDimension Inc.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy